| Filed On | Filing |
|---|---|
| 03 Nov 2022 |
8-K/A: Submission of Matters to a Vote of Security Holders
On June 17, 2022, Corvus Pharmaceuticals, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Report”) disclosing the results of voting at the Company’s 2022 Annual Meeting of Stockholders (the “Annual Meeting”) held o... |
Loading...
